elafibranor
Sign in to saveElafibranor, sold under the brand name Iqirvo, is a medication used for the treatment of primary biliary cholangitis.
~3 min read
Encyclopedic overview
8 sectionsContents
- Medical uses
- Adverse effects
- History
- Society and culture
- Legal status
- Names
- Research
- References
Elafibranor, sold under the brand name Iqirvo, is a medication used for the treatment of primary biliary cholangitis.
Elafibranor is a dual PPARα/δ agonist. Elafibranor and its main active metabolite GFT1007 are peroxisome proliferator-activated receptor (PPAR) agonists, both of which activate PPAR-alpha, PPAR-gamma, and PPAR-delta in vitro.
Excerpted from Wikipedia’s “elafibranor” article, available under the CC BY-SA 4.0 licence.